CXCL10 and cardiovascular disorder: Zaghlool et al. showed that altered methylation at the NLRC5 locus associates with several inflammatory markers, including CXCL10 and CXCL11, with pathway analyses linking it to disease states in which NLRC5 dysfunction is implicated such as cancer and cardiovascular disease [43].